2',3',5'-三乙酰尿苷 (4105-38-8)

2’,3’,5’-三乙酰尿苷;

2,3,5-三乙酰尿苷;

2',3',5-TRI-ACETYLURIDINE;

EINECS 223-881-5;

Vistogard;

Uridine 2',3',5'-triacetate;

2',3',5'-Tri-O-acetyl-rU;

2’,3’,5’-Triacetyluridine;

Uridine, 2',3',5'-triacetate;

2`,3`,5`-Tracetyluridine;

TAU;

2',3',5'-Tri-O-acety;

Tri-O-acetyl uridine;

2',3',5'-Tri0acetyluridine;

(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate;

2',3',5'-Tri-O-acetyluridine;

UNII-2WP61F175M;

2',3',5'-Triacetyluridine;

O2',O3',O5'-triacetyl-uridine;

uridine triacetate;

Xuriden;

2',3',5'-O-triacetyluridine;

2`,3`,5`-Triacetyluridine;

2',3',5'-trioacetyluridine;

MFCD00023795;

Vistonuridine;